MANDI BROWN: Open Payments
NPI 1033156096 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 25 payments from 8 companies in 2025. Trend: 2023 $153 · 2024 $183 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| ABBVIE INC. | 6 | $147 |
| Lilly USA, LLC | 3 | $57 |
| Novo Nordisk Inc | 2 | $48 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: AIRSUPRA, UBRELVY, MOUNJARO, BREZTRI, VRAYLAR, NUZYRA, Rybelsus, CAPLYTA.
Industry payments across OK — which companies pay providers there.
